2019 Speakers

 

 

Kate Adcock, Director Of Research And Innovation, The Muscular Dystrophy U.K.

Kate Adcock | Director Of Research And Innovation | The Muscular Dystrophy U.K. » speaking at PPMA 2019

Jeonghoon Ahn, Director, National Evidence-based Healthcare Collaborating Agency

Jeonghoon Ahn | Director | National Evidence-based Healthcare Collaborating Agency » speaking at PPMA 2019

John Alter, Vice President Pricing And Market Access, Pfizer

John Alter | Vice President Pricing And Market Access | Pfizer » speaking at PPMA 2019

Mauricio Alvarez Reyes, Market Access Director, Tesaro

Mauricio Alvarez Reyes | Market Access Director | Tesaro » speaking at PPMA 2019

Katerina Anokhina, Director, Medical Affairs, Uk And Ireland, Alexion Pharma UK

Katerina Anokhina | Director, Medical Affairs, Uk And Ireland | Alexion Pharma UK » speaking at PPMA 2019

Diego Ardigo, Research And Development Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Diego Ardigo | Research And Development Rare Diseases Unit Head | Chiesi Farmaceutici SpA » speaking at PPMA 2019

Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, National Institute for Health and Disability Insurance RIZIV-INAMI

Nadeem Ashraf, Medical Advisor - Diabetes, N/A

Nadeem Ashraf | Medical Advisor - Diabetes | N/A » speaking at PPMA 2019

Philip Aubrey, Associate Director Market Access Biosimilars, Uk, Netherlands And Ireland, Biogen

Philip Aubrey | Associate Director Market Access Biosimilars, Uk, Netherlands And Ireland | Biogen » speaking at PPMA 2019

Segolene Ayme, Founder Of Orphanet And Rare Disease Expert In Residence, ICM, Paris

Segolene Ayme | Founder Of Orphanet And Rare Disease Expert In Residence | ICM, Paris » speaking at PPMA 2019

Katja Berg, Vice President Of Operations And Payers Intelligence, Sanofi

Katja Berg | Vice President Of Operations And Payers Intelligence | Sanofi » speaking at PPMA 2019

Inge Bliestle, Commercial Director, Actelion

Inge Bliestle | Commercial Director | Actelion » speaking at PPMA 2019

Axel Boehnke, Director Market Access (Global Responsibility), MorphoSys AG

Axel Boehnke | Director Market Access (Global Responsibility) | MorphoSys AG » speaking at PPMA 2019

Luc Boileau, Président-Directeur General, Inesss

Luc Boileau | Président-Directeur General | Inesss » speaking at PPMA 2019

David Boothe, Endocrinology Lead, HRA-Pharma

David Boothe | Endocrinology Lead | HRA-Pharma » speaking at PPMA 2019

Hassan Bruneo, Associate Director, Alnylam Switzerland Gmbh

Hassan Bruneo | Associate Director | Alnylam Switzerland Gmbh » speaking at PPMA 2019

Anna Bucsics, Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)

Anna Bucsics | Project Advisor | Mechanism of Coordinated Access to orphan medicinal products (MoCA) » speaking at PPMA 2019

JUAN CASTANO, Lawyer health regulation enforceability, Management Science For Health

Deven Chauhan, Senior Director, Value Evidence Leader, GlaxoSmithKline

Deven Chauhan | Senior Director, Value Evidence Leader | GlaxoSmithKline » speaking at PPMA 2019

Francis Crawley, Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer), Good Clinical Practice Alliance (GCPA)

Francis Crawley | Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer) | Good Clinical Practice Alliance (GCPA) » speaking at PPMA 2019

Don Creighton, Managing Director, Life Sciences Practice, Huron

Don Creighton | Managing Director, Life Sciences Practice | Huron » speaking at PPMA 2019

Mike Crosher, Value And Access Director, Chugai Pharma UK

Mike Crosher | Value And Access Director | Chugai Pharma UK » speaking at PPMA 2019

Omar Dabbous, Vice President Health Economics And Outcomes Research, AveXis Inc

Omar Dabbous | Vice President Health Economics And Outcomes Research | AveXis Inc » speaking at PPMA 2019

Charles De Cidrac, Director Of Health Insurance, AXA

Charles De Cidrac | Director Of Health Insurance | AXA » speaking at PPMA 2019

Carla Deakin, Associate Director, Office For Market Access, NICE

Carla Deakin | Associate Director, Office For Market Access | NICE » speaking at PPMA 2019

Stephen Deitch, Vice President, Charles River Associates

Mark Duman, Nw Service Champion, Diabetes U.K.

Mark Duman | Nw Service Champion | Diabetes U.K. » speaking at PPMA 2019

Jenny Ebert, National Account Director, Genzyme Sanofi Corp

Jenny Ebert | National Account Director | Genzyme Sanofi Corp » speaking at PPMA 2019

David Elvira Martinez, Director Of The Catalan Health Service, CatSalut, Catalunya Health Service

David Elvira Martinez | Director Of The Catalan Health Service | CatSalut, Catalunya Health Service » speaking at PPMA 2019

Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband

Michael Ermisch | Specialist, Department Of Pharmaceuticals | G.K.V. Spitzenverband » speaking at PPMA 2019

Valerie Faillat, Head Of Sanofi Espoir Foundation, Sanofi

Valerie Faillat | Head Of Sanofi Espoir Foundation | Sanofi » speaking at PPMA 2019

Diar Fattah, Associate Director Of Medicines Optimisation, N.H.S._Dartford Gravesham and Swanley C.C.G.

Diar Fattah | Associate Director Of Medicines Optimisation | N.H.S._Dartford Gravesham and Swanley C.C.G. » speaking at PPMA 2019

Matteo Ferrario, Value Strategy Manager, Roche

Matteo Ferrario | Value Strategy Manager | Roche » speaking at PPMA 2019

Martina Flammer, Senior Vice President, Head Of Customer Value, Boehringer Ingelheim Pharma GmbH & Co. KG

Alejandra (Sandra) Garitonandía, Business Development, Vistex

Alejandra (Sandra) Garitonandía | Business Development | Vistex » speaking at PPMA 2019

Oliver Gassner, Head Digital Health Intelligence | Emea, Bayer

Oliver Gassner | Head Digital Health Intelligence | Emea | Bayer » speaking at PPMA 2019

Ivan Glushkov, External Affairs Department Director, S.T.A.D.A.

Ivan Glushkov | External Affairs Department Director | S.T.A.D.A. » speaking at PPMA 2019

Josie Godfrey, Independent, Duchenne

Josie Godfrey | Independent | Duchenne » speaking at PPMA 2019

Adrian Griffin, Vice President, Hta And Reimbursement Policy, Johnson & Johnson

Adrian Griffin | Vice President, Hta And Reimbursement Policy | Johnson & Johnson » speaking at PPMA 2019

Tony Hebden, Vice President Of Health Economics And Outcomes Research, AbbVie

Tony Hebden | Vice President Of Health Economics And Outcomes Research | AbbVie » speaking at PPMA 2019

Birgit Holz, Global Head Of Contracting Innovation, Sanofi

Birgit Holz | Global Head Of Contracting Innovation | Sanofi » speaking at PPMA 2019

Patrick Hopkinson, Executive Director, Wwheor Markets, Bristol-Myers Squibb

Lucy Hoppe, Clinical Effectiveness Manager (Evidence Synthesis) In The Clinical Effectiveness Team, Bupa

Lucy Hoppe | Clinical Effectiveness Manager (Evidence Synthesis) In The Clinical Effectiveness Team | Bupa » speaking at PPMA 2019

Nigel Hughes, Scientific Director, Janssen

Wills Hughes-Wilson, Head Of Patient Access And Commercial Planning, Mereo BioPharma

Dawn Ireland, President, CDH International

Dawn Ireland | President | CDH International » speaking at PPMA 2019

Daniel Jackson, Global Head Of Market Access, Solutions And Strategy, UCB

Daniel Jackson | Global Head Of Market Access, Solutions And Strategy | UCB » speaking at PPMA 2019

David Jakouloff, Global Head of Market Access, DMD, PTC Therapeutics

David Jakouloff | Global Head of Market Access, DMD | PTC Therapeutics » speaking at PPMA 2019

Saira Jan, Director Of Pharmacy Strategy And Clinical Integration, Blue Cross Blue Shield of New Jersey

Saira Jan | Director Of Pharmacy Strategy And Clinical Integration | Blue Cross Blue Shield of New Jersey » speaking at PPMA 2019

Wendy Jory, Head of Global Pricing and Contracting Strategies, GlaxoSmithKline

Wendy Jory | Head of Global Pricing and Contracting Strategies | GlaxoSmithKline » speaking at PPMA 2019

Rosemary Jose, Associate Director of Strategic Market Access, Pharmerit International

Rosemary Jose | Associate Director of Strategic Market Access | Pharmerit International » speaking at PPMA 2019

Navin Joshi, Global Head Of Pricing, Classic And Established Products. Global Pharma, GlaxoSmithKline

Navin Joshi | Global Head Of Pricing, Classic And Established Products. Global Pharma | GlaxoSmithKline » speaking at PPMA 2019

Marcela Junqueira, Head Of Strategic Affairs And Health Economics, Janssen Pharmaceutical

Marcela Junqueira | Head Of Strategic Affairs And Health Economics | Janssen Pharmaceutical » speaking at PPMA 2019

Sachin Kamal-Bahl, Vice President And Head, Global Health And Value Innovation Center, Pfizer

Sachin Kamal-Bahl | Vice President And Head, Global Health And Value Innovation Center | Pfizer » speaking at PPMA 2019

Nicki Kang, Head Of Pricing Uk And Ireland, Merck Group

Nicki Kang | Head Of Pricing Uk And Ireland | Merck Group » speaking at PPMA 2019

Daniel Knecht, Vice President, Clinical Strategy And Policy, Aetna

Alison Kneen, Practice Lead, DRG Abacus

Jolanda Koenders, Head Of Pricing And Market Access Pharma, Novartis

Jolanda Koenders | Head Of Pricing And Market Access Pharma | Novartis » speaking at PPMA 2019

Brett Kopelan, Executive Director, DebRa of America

Brett Kopelan | Executive Director | DebRa of America » speaking at PPMA 2019

Adam Kundzewicz, Senior Global Payer Strategy Manager, Head Of Pricing, Boehringer Ingelheim Pharma GmbH & Co. KG

Giovanny Leon, Pricing And Market Access Director For Latin America And Canada, Novartis Ag

Sandy Leonard, Vice President Of Medical Evidence And Observational Research, AstraZeneca

Sandy Leonard | Vice President Of Medical Evidence And Observational Research | AstraZeneca » speaking at PPMA 2019

Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer

Friedhelm Leverkus | Director Health Technology Assessment And Outcomes Research | Pfizer » speaking at PPMA 2019

Sune Lindgaard, Chief Of Business Intelligence, Amgros, Denmark

Sune Lindgaard | Chief Of Business Intelligence | Amgros, Denmark » speaking at PPMA 2019

Qing Liu, Head of Biostatistics and Data Management, Amicus Therapeutics Inc

Qing Liu | Head of Biostatistics and Data Management | Amicus Therapeutics Inc » speaking at PPMA 2019

Catarina Lopes Pereira, Market Access Manager, Medicines for Europe

Catarina Lopes Pereira | Market Access Manager | Medicines for Europe » speaking at PPMA 2019

Elena Lungu, Manager, NPDUIS, PMPRB

Elena Lungu | Manager, NPDUIS | PMPRB » speaking at PPMA 2019

Mark Macgregor, Interim Medical Director, Acute Services, Nhs Scotland

Mark Macgregor | Interim Medical Director, Acute Services | Nhs Scotland » speaking at PPMA 2019

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen | Medical Director | Norwegian Medicines Agency, Norway » speaking at PPMA 2019

Joerg Mahlich, Head Heor, Janssen Pharmaceutical K.K.

Farzana Malik, Vice President Market Access, Vicarius Pharma

Farzana Malik | Vice President Market Access | Vicarius Pharma » speaking at PPMA 2019

Andrea Mantovani, Market Access Director, Abbott Diagnostics

Andrea Mantovani | Market Access Director | Abbott Diagnostics » speaking at PPMA 2019

Eva Marchese, Vice President, CRA International

Marco Marchetti, Director Of The National Center For Health Technology Assessment, Istituto Superiore di Sanita

Marco Marchetti | Director Of The National Center For Health Technology Assessment | Istituto Superiore di Sanita » speaking at PPMA 2019

Anne Marciniak, Head of Market Access, Europe, Aimmune

Anne Marciniak | Head of Market Access, Europe | Aimmune » speaking at PPMA 2019

Alen Marijam`, Heor Senior Manager, Em, GlaxoSmithKline

Alen Marijam` | Heor Senior Manager, Em | GlaxoSmithKline » speaking at PPMA 2019

Kevin Mayo, Head, Global Market Access - New Products, Shire Pharmaceuticals

Margaret Mcdonald, Senior Director, Global Market Access, Pfizer

Margaret Mcdonald | Senior Director, Global Market Access | Pfizer » speaking at PPMA 2019

Elizabeth Mckenna, Head Of Market Access Uk And Ireland, Vertex Pharmaceuticals

Elizabeth Mckenna | Head Of Market Access Uk And Ireland | Vertex Pharmaceuticals » speaking at PPMA 2019

Paul Mcloughlin, VP of Market Access & Phase IV Solutions, Covance

Paul Mcloughlin | VP of Market Access & Phase IV Solutions | Covance » speaking at PPMA 2019

Soniya Mokashi, Global Senior Medical Affairs Physician, Norgine

Soniya Mokashi | Global Senior Medical Affairs Physician | Norgine » speaking at PPMA 2019

Patrick Mollon, Former Director Gheore, Shire

Tal Morginstin, Director, Nlhs (National List Of Health Services) Assessment Division, Ministry of Health

Tal Morginstin | Director, Nlhs (National List Of Health Services) Assessment Division | Ministry of Health » speaking at PPMA 2019

Aurelie Moser, Head of Access LABs, Roche

Aurelie Moser | Head of Access LABs | Roche » speaking at PPMA 2019

Thomas Mueller, Head Of Directorate General 1 "Drugs, Medical Devices, Biotechnology", Bundesministerium fur Gesundheit

Thomas Mueller | Head Of Directorate General 1 'Drugs, Medical Devices, Biotechnology' | Bundesministerium fur Gesundheit » speaking at PPMA 2019

Diane Munch, Head Of Global Pricing, Patient And Health Impact, Pfizer

Diane Munch | Head Of Global Pricing, Patient And Health Impact | Pfizer » speaking at PPMA 2019

Sue Naeyaert, Global Head Government Affairs And Policy Biosimilars, Fresenius Kabi

Sue Naeyaert | Global Head Government Affairs And Policy Biosimilars | Fresenius Kabi » speaking at PPMA 2019

Alexander Natz, Secretary General, EUCOPE

Alexander Natz | Secretary General | EUCOPE » speaking at PPMA 2019

Paul Newton, Director Strategic Pricing, UCB

Paul Newton | Director Strategic Pricing | UCB » speaking at PPMA 2019

Enkeleida Nikai, Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea), Janssen Pharmaceutical

Enkeleida Nikai | Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea) | Janssen Pharmaceutical » speaking at PPMA 2019

Waldemar Ockert, Director, RWI Business Market Analytics, Astellas

Waldemar Ockert | Director, RWI Business Market Analytics | Astellas » speaking at PPMA 2019

Irina Odnoletkova, VP Health Technology Assessment, Apogenix

Irina Odnoletkova | VP Health Technology Assessment | Apogenix » speaking at PPMA 2019

Melvin Olson, Global Head Rwd Strategy And Innovation, Novartis Pharma

Melvin Olson | Global Head Rwd Strategy And Innovation | Novartis Pharma » speaking at PPMA 2019

Vitaly Omelyanovskiy, General Director, Center Of Healthcare Quality Assessment And Control, Ministry of Health

Nneka Onwudiwe, Founder and Chief Executive Officer, Pharmacoeconomics Consultants of America

Nneka Onwudiwe | Founder and Chief Executive Officer | Pharmacoeconomics Consultants of America » speaking at PPMA 2019

Mario Ouwens, Statistical Science Director, Astra Zeneca

Mario Ouwens | Statistical Science Director | Astra Zeneca » speaking at PPMA 2019

Elizabeth Owen, Head Of Translational Research Development, The Muscular Dystrophy U.K.

Elizabeth Owen | Head Of Translational Research Development | The Muscular Dystrophy U.K. » speaking at PPMA 2019

Melissa Paige, Uva Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate, U.V.A. Health System

Melissa Paige | Uva Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate | U.V.A. Health System » speaking at PPMA 2019

Elena Panitti, Global Rwe Capability Building Lead, Novartis

Elena Panitti | Global Rwe Capability Building Lead | Novartis » speaking at PPMA 2019

Detlev Parow, Head Pharmaceutical Department, D.A.K.

Detlev Parow | Head Pharmaceutical Department | D.A.K. » speaking at PPMA 2019

Geert Pelsmaeker, General Manager, Leaphy

Geert Pelsmaeker | General Manager | Leaphy » speaking at PPMA 2019

Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer Ingelheim Biopharmaceuticals Gmbh

Marco Penske | Head Of Market Access And Health Care Affairs | Boehringer Ingelheim Biopharmaceuticals Gmbh » speaking at PPMA 2019

Dan Pettitt, Global Head Of Immunology Market Access, Johnson & Johnson

Dan Pettitt | Global Head Of Immunology Market Access | Johnson & Johnson » speaking at PPMA 2019

Ed Pezalla, Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy, Aetna

Ed Pezalla | Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy | Aetna » speaking at PPMA 2019

Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.

Andres Pichon Riviere | Executive Director And Director Of Health Technology Assessment And Economic Evaluations | I.E.C.S. » speaking at PPMA 2019

Lara Pippo, Head Of Market Access, C.S.L. Behring Spa

Lara Pippo | Head Of Market Access | C.S.L. Behring Spa » speaking at PPMA 2019

Adam Plich, Former Vice President, Head Of Pricing And Market Access Europe, Teva

Adam Plich | Former Vice President, Head Of Pricing And Market Access Europe | Teva » speaking at PPMA 2019

Robert Popovian, Vice President Of Government Relations, Pfizer

Robert Popovian | Vice President Of Government Relations | Pfizer » speaking at PPMA 2019

Diann Potestio, VP Market Access, Ascendis Pharma A/S

Diann Potestio | VP Market Access | Ascendis Pharma A/S » speaking at PPMA 2019

Rafaat Rahmani, President, Lifescience Dynamics Ltd

Rafaat Rahmani | President | Lifescience Dynamics Ltd » speaking at PPMA 2019

Marco Rauland, Vice President, Map GmAndE And Training Academy, Global Market Access And Pricing, Biopharma| Global Operations, Merck Group

S Ravetkar, Executive Director, Serum Institute of India Ltd

S Ravetkar | Executive Director | Serum Institute of India Ltd » speaking at PPMA 2019

Ajan Reginald, Chief Executive Officer, Celixir

Andreia Ribeiro, Engagement Manager, Lifescience Dynamics Ltd

Andreia Ribeiro | Engagement Manager | Lifescience Dynamics Ltd » speaking at PPMA 2019

Giuseppe Rosano, Member Of The Cardiovascular Working Party, European Medicines Agency

Giuseppe Rosano | Member Of The Cardiovascular Working Party | European Medicines Agency » speaking at PPMA 2019

Katja Rudell, Honorary Research Fellow, Queen Mary University of London

Katja Rudell | Honorary Research Fellow | Queen Mary University of London » speaking at PPMA 2019

Igor Rudychev, Senior Director, Business Insights, AstraZeneca

Igor Rudychev | Senior Director, Business Insights | AstraZeneca » speaking at PPMA 2019

Peter Rutherford, Global Medical Lead Of Orphan Renal Diseases, Vifor Pharma Group

Peter Rutherford | Global Medical Lead Of Orphan Renal Diseases | Vifor Pharma Group » speaking at PPMA 2019

Emily Saadi, Senior Undergraduate, Health Care Policy & Management, Georgetown University

Emily Saadi | Senior Undergraduate, Health Care Policy & Management | Georgetown University » speaking at PPMA 2019

Ryan Saadi, VP, Global Market Access, CSL Behring

Ryan Saadi | VP, Global Market Access | CSL Behring » speaking at PPMA 2019

Steve Sandor, Vice President, Market Access and Trade, Paratek Pharmaceuticals , Inc.

Steve Sandor | Vice President, Market Access and Trade | Paratek Pharmaceuticals , Inc. » speaking at PPMA 2019

Stefan Scherer, Vice President Head Of Early Development Strategy, McKesson Specialty Health The U.S. Oncology Network

Stefan Scherer | Vice President Head Of Early Development Strategy | McKesson Specialty Health The U.S. Oncology Network » speaking at PPMA 2019

Gundula Schneidewind, Managing Director, Takeda Belgium

Gundula Schneidewind | Managing Director | Takeda Belgium » speaking at PPMA 2019

Michael Schroter, Partner, Viopas Partners

Michael Schroter | Partner | Viopas Partners » speaking at PPMA 2019

Ad Schuurman, Senior Advisor International Affairs, National Health Care Institute (ZIN), the Netherlands

Ad Schuurman | Senior Advisor International Affairs | National Health Care Institute (ZIN), the Netherlands » speaking at PPMA 2019

Ayman Semaan, Head of Market Access, Algorithm

Ayman Semaan | Head of Market Access | Algorithm » speaking at PPMA 2019

Simon Shohet, Senior Director, Global Market Access And Pricing, Ipsen

Simon Shohet | Senior Director, Global Market Access And Pricing | Ipsen » speaking at PPMA 2019

Maurício Silva De Lima, Vice President, Us Medical Affairs Head, Spectrum Medical Unit, Genentech

Tamir Singer, Head Of Commercial Development, Specialised Commissioning, NHS England

Anindita Sinha, Director, Global Market Access, Pfizer

Anindita Sinha | Director, Global Market Access | Pfizer » speaking at PPMA 2019

Matt Slabbert, Head Of Market Access, Advocacy And Policy, Anz, Bayer Pharmaceuticals

Matt Slabbert | Head Of Market Access, Advocacy And Policy, Anz | Bayer Pharmaceuticals » speaking at PPMA 2019

Erik Smets, Vice President And Head Of Patient Experience And Value, UCB Biopharma

Erik Smets | Vice President And Head Of Patient Experience And Value | UCB Biopharma » speaking at PPMA 2019

Jan Span, Member Of The Cross-Committee Task Force On Registries And Senior Clinical Assessor, Medicines Evaluation Board The Netherlands

Jan Span | Member Of The Cross-Committee Task Force On Registries And Senior Clinical Assessor | Medicines Evaluation Board The Netherlands » speaking at PPMA 2019

Anastasiya Stepanova, State Authorities Manager, JSC Nizhpharm

Anastasiya Stepanova | State Authorities Manager | JSC Nizhpharm » speaking at PPMA 2019

Richard Stephens, Chair Of Consumer Liaison Group, National Cancer Research Institute (NCRI)

Richard Stephens | Chair Of Consumer Liaison Group | National Cancer Research Institute (NCRI) » speaking at PPMA 2019

Lotte Steuten, Associate Faculty Member, Fred Hutchinson Cancer Research Center

Simon Swift, Managing Director, Methods Analytics

Simon Swift | Managing Director | Methods Analytics » speaking at PPMA 2019

Bertrand Tardivel, General Manager, Frehel GmbH

Bertrand Tardivel | General Manager | Frehel GmbH » speaking at PPMA 2019

Renske Ten Ham, Phd Candidate, Utrecht University

Renske Ten Ham | Phd Candidate | Utrecht University » speaking at PPMA 2019

Gwilym Thompson, Director Worldwide Heor, BMS

Gwilym Thompson | Director Worldwide Heor | BMS » speaking at PPMA 2019

Daria Tolkacheva, Head Of Health Economics, JSC BIOCAD

Daria Tolkacheva | Head Of Health Economics | JSC BIOCAD » speaking at PPMA 2019

Jorg Tomeczkowski, Head Of Market Access, Janssen Cilag Germany

Jorg Tomeczkowski | Head Of Market Access | Janssen Cilag Germany » speaking at PPMA 2019

Keiko Tone, VP Global Market Access, Shionogi Inc

Keiko Tone | VP Global Market Access | Shionogi Inc » speaking at PPMA 2019

Ariella Toren, Director Of Medicine And Medical Technologies, Hmos Department, Israel - Ministry Of Health

Ariella Toren | Director Of Medicine And Medical Technologies, Hmos Department | Israel - Ministry Of Health » speaking at PPMA 2019

Dr Josep Torrent-Farnell, Medicines Department, Catalan Health Service

Isabel Torres, Vice President Market Access, Public Affairs And Patient Advocacy For Europe And Canada, Takeda

Isabel Torres | Vice President Market Access, Public Affairs And Patient Advocacy For Europe And Canada | Takeda » speaking at PPMA 2019

Sheela Upadhyaya, Associate Director Highly Specialised Technologies, National Institute for Health and Care Excellence

Sheela Upadhyaya | Associate Director Highly Specialised Technologies | National Institute for Health and Care Excellence » speaking at PPMA 2019

Bart Van Den Daele, Head of External Affairs – Director Market Access, Gilead Sciences Belgium Bvba

Bart Van Den Daele | Head of External Affairs – Director Market Access | Gilead Sciences Belgium Bvba » speaking at PPMA 2019

Goedele Van Haasteren, Hta Specialist, Bundesamt fur Gesundheit

Christina Vandoros, Director, Macroeconomics & Health Policy - EMEA, Janssen

Christina Vandoros | Director, Macroeconomics & Health Policy - EMEA | Janssen » speaking at PPMA 2019

Kart Veliste, Chief Specialist at Department of Medicines and Medical Devices, Haigekassa Estonia

Kart Veliste | Chief Specialist at Department of Medicines and Medical Devices | Haigekassa Estonia » speaking at PPMA 2019

Bart Vermeulen, Deputy Director Healthcare At Office Of The Minister Of Social Affairs And Public Health, Belgian Federal Government

Bart Vermeulen | Deputy Director Healthcare At Office Of The Minister Of Social Affairs And Public Health | Belgian Federal Government » speaking at PPMA 2019

Jaume Vidal, Policy Advisor, Eu Projects, Health Action International

Jaume Vidal | Policy Advisor, Eu Projects | Health Action International » speaking at PPMA 2019

Reg Waldeck, Market Access Strategy Leader, Bayer Corp

Reg Waldeck | Market Access Strategy Leader | Bayer Corp » speaking at PPMA 2019

David Watson, Director Pricing And Reimbursement, Association of the British Pharmaceutical Industry

David Watson | Director Pricing And Reimbursement | Association of the British Pharmaceutical Industry » speaking at PPMA 2019

Lindsay Weaver, Executive Director, Children Living With Inherited Metabolic Diseases

Lindsay Weaver | Executive Director | Children Living With Inherited Metabolic Diseases » speaking at PPMA 2019

David Williams, Chief Medical Officer, Visformatics

David Williams | Chief Medical Officer | Visformatics » speaking at PPMA 2019

Fabrizio Zucca, Director Patient Access Dach, Sobi

Fabrizio Zucca | Director Patient Access Dach | Sobi » speaking at PPMA 2019

 

DOWNLOAD PROSPECTUS